{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:46:13Z","timestamp":1791837973340,"version":"4.3.4"},"reference-count":57,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["5T32HL007149-49"],"award-info":[{"award-number":["5T32HL007149-49"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01HL155193"],"award-info":[{"award-number":["R01HL155193"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Vessels, Thrombosis & Hemostasis"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bvth.2026.100214","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:42:00Z","timestamp":1788540120000},"page":"100214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Platelets in sickle cell disease: biomarkers, mediators, and lessons from clinical trials"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5074-9745","authenticated-orcid":false,"given":"Joanne C.","family":"Alfred","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5529-7847","authenticated-orcid":false,"given":"Erica M.","family":"Sparkenbaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.bvth.2026.100214_bib1","doi-asserted-by":"crossref","first-page":"e585","DOI":"10.1016\/S2352-3026(23)00118-7","article-title":"Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the Global Burden of Disease Study 2021","volume":"10","year":"2023","journal-title":"Lancet Haematol"},{"issue":"10091","key":"10.1016\/j.bvth.2026.100214_bib2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0140-6736(17)30193-9","article-title":"Sickle cell disease","volume":"390","author":"Ware","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bvth.2026.100214_bib3","doi-asserted-by":"crossref","first-page":"ITC1","DOI":"10.7326\/AITC202101190","article-title":"Sickle cell disease","volume":"174","author":"Pecker","year":"2021","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.bvth.2026.100214_bib4","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0022-2143(97)90005-6","article-title":"Platelet activation and platelet-erythrocyte aggregates in patients with sickle cell anemia","volume":"129","author":"Wun","year":"1997","journal-title":"J Lab Clin Med"},{"issue":"10","key":"10.1016\/j.bvth.2026.100214_bib5","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.3324\/haematol.2019.239343","article-title":"Thromboinflammatory mechanisms in sickle cell disease - challenging the hemostatic balance","volume":"105","author":"Conran","year":"2020","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.bvth.2026.100214_bib6","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1182\/blood-2015-09-618538","article-title":"Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology","volume":"127","author":"Zhang","year":"2016","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.bvth.2026.100214_bib7","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMra0804411","article-title":"Pulmonary complications of sickle cell disease","volume":"359","author":"Gladwin","year":"2008","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.bvth.2026.100214_bib8","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2024-066842","article-title":"Health supervision for children and adolescents with sickle cell disease: clinical report","volume":"154","author":"Yates","year":"2024","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.bvth.2026.100214_bib9","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1182\/blood.V98.6.1955","article-title":"P-selectin mediates the adhesion of sickle erythrocytes to the endothelium","volume":"98","author":"Matsui","year":"2001","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.bvth.2026.100214_bib10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/108155899904700307","article-title":"Platelet-erythrocyte adhesion in sickle cell disease","volume":"47","author":"Wun","year":"1999","journal-title":"J Investig Med"},{"issue":"1","key":"10.1016\/j.bvth.2026.100214_bib11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1113\/expphysiol.2007.038588","article-title":"Role of nitric oxide and prostacyclin as vasoactive hormones released by the endothelium","volume":"93","author":"Mitchell","year":"2008","journal-title":"Exp Physiol"},{"issue":"5","key":"10.1016\/j.bvth.2026.100214_bib12","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/jth.13302","article-title":"Platelet signaling: a complex interplay between inhibitory and activatory networks","volume":"14","author":"Bye","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"suppl 1","key":"10.1016\/j.bvth.2026.100214_bib13","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.thromres.2007.03.011","article-title":"The role of von Willebrand factor in thrombus formation","volume":"120","author":"Ruggeri","year":"2007","journal-title":"Thromb Res"},{"issue":"3","key":"10.1016\/j.bvth.2026.100214_bib14","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.thromres.2015.06.019","article-title":"Von Willebrand factor-A1 domain binds platelet glycoprotein Ib\u03b1 in multiple states with distinctive force-dependent dissociation kinetics","volume":"136","author":"Ju","year":"2015","journal-title":"Thromb Res"},{"issue":"1","key":"10.1016\/j.bvth.2026.100214_bib15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.15171\/apb.2019.005","article-title":"Signaling pathways of receptors involved in platelet activation and shedding of these receptors in stored platelets","volume":"9","author":"Amelirad","year":"2019","journal-title":"Adv Pharm Bull"},{"key":"10.1016\/j.bvth.2026.100214_bib16","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4310816","article-title":"Induction of NLRP3 inflammasome activation by heme in human endothelial cells","volume":"2018","author":"Erdei","year":"2018","journal-title":"Oxid Med Cell Longev"},{"issue":"3","key":"10.1016\/j.bvth.2026.100214_bib17","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1182\/blood-2013-04-495887","article-title":"Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease","volume":"123","author":"Belcher","year":"2014","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.bvth.2026.100214_bib18","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1111\/jth.12710","article-title":"Activated platelets present high mobility group box 1 to neutrophils, inducing autophagy and promoting the extrusion of neutrophil extracellular traps","volume":"12","author":"Maugeri","year":"2014","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.1016\/j.bvth.2026.100214_bib19","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1160\/TH14-05-0455","article-title":"Neutrophil extracellular traps (NETs) and the role of platelets in infection","volume":"112","author":"Andrews","year":"2014","journal-title":"Thromb Haemost"},{"issue":"20","key":"10.1016\/j.bvth.2026.100214_bib20","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1182\/bloodadvances.2018021709","article-title":"The platelet NLRP3 inflammasome is upregulated in sickle cell disease via HMGB1\/TLR4 and Bruton tyrosine kinase","volume":"2","author":"Vogel","year":"2018","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.bvth.2026.100214_bib21","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bbrc.2016.12.161","article-title":"The NLRP3 inflammasome and Bruton\u2019s tyrosine kinase in platelets co-regulate platelet activation, aggregation, and in vitro thrombus formation","volume":"483","author":"Murthy","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bvth.2026.100214_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/srep32188","article-title":"Effects of IL-1\u03b2, IL-6 and IL-8 on erythrocytes, platelets and clot viscoelasticity","volume":"6","author":"Bester","year":"2016","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.bvth.2026.100214_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167899","article-title":"Hbs binding to GP1b\u03b1 activates platelets in sickle cell disease","volume":"11","author":"Annarapu","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bvth.2026.100214_bib24","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.bbrc.2021.03.115","article-title":"NLRP3 inflammasome and Bruton tyrosine kinase inhibition interferes with upregulated platelet aggregation and in vitro thrombus formation in sickle cell mice","volume":"555","author":"Vogel","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.bvth.2026.100214_bib25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1164\/rccm.201807-1370OC","article-title":"Platelet extracellular vesicles drive inflammasome-IL-1\u03b2-dependent lung injury in sickle cell disease","volume":"201","author":"Vats","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.bvth.2026.100214_bib26","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/bjh.17941","article-title":"Interleukin-1 receptor antagonism leads to improved anaemia in a murine model of sickle cell disease and is associated with reduced ex vivo platelet-mediated erythrocyte sickling","volume":"196","author":"Venugopal","year":"2022","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.bvth.2026.100214_bib27","doi-asserted-by":"crossref","first-page":"7997","DOI":"10.4049\/jimmunol.0802884","article-title":"Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4\/MyD88 and the cGMP-dependent protein kinase pathway","volume":"182","author":"Zhang","year":"2009","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.bvth.2026.100214_bib28","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.174575","article-title":"High-mobility group box 1 increases platelet surface P2Y12 and platelet activation in sickle cell disease","volume":"9","author":"Nolfi-Donegan","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.bvth.2026.100214_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102205","article-title":"Heme stimulates platelet mitochondrial oxidant production to induce targeted granule secretion","volume":"48","author":"Annarapu","year":"2021","journal-title":"Redox Biol"},{"issue":"2","key":"10.1016\/j.bvth.2026.100214_bib30","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3324\/haematol.2020.246488","article-title":"Heme induces human and mouse platelet activation through C-type-lectin-like receptor-2","volume":"106","author":"Bourne","year":"2021","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.bvth.2026.100214_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2025.103168","article-title":"Evaluation of the PDPN\/CLEC-2 pathway as a mediator of platelet and coagulation activation in sickle cell disease","volume":"9","author":"Borba-Junior","year":"2025","journal-title":"Res Pract Thromb Haemost"},{"issue":"5","key":"10.1016\/j.bvth.2026.100214_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2020.102852","article-title":"Thrombin generation in children with sickle cell anemia is higher in the presence of platelets","volume":"59","author":"Menon","year":"2020","journal-title":"Transfus Apher Sci"},{"issue":"8","key":"10.1016\/j.bvth.2026.100214_bib33","doi-asserted-by":"crossref","first-page":"585","DOI":"10.4103\/ijccm.IJCCM_49_18","article-title":"The platelet count and its implications in sickle cell disease patients admitted for intensive care","volume":"22","author":"Shome","year":"2018","journal-title":"Indian J Crit Care Med"},{"key":"10.1016\/j.bvth.2026.100214_bib34","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3656717","article-title":"Changes in blood profile from steady state in patients with sickle cell anemia admitted for vaso-occlusive crisis and acute chest syndrome","volume":"2020","author":"Klouda","year":"2020","journal-title":"Adv Hematol"},{"issue":"3","key":"10.1016\/j.bvth.2026.100214_bib35","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s00277-026-06859-8","article-title":"Platelet-neutrophil ratio as a potential biomarker for stroke risk stratification in children and young adults with sickle cell anaemia in resource poor settings","volume":"105","author":"Nri-Ezedi","year":"2026","journal-title":"Ann Hematol"},{"issue":"5","key":"10.1016\/j.bvth.2026.100214_bib36","doi-asserted-by":"crossref","first-page":"821","DOI":"10.4314\/ejhs.v33i5.12","article-title":"Neutrophil-lymphocyte, platelet-neutrophil, and platelet-lymphocyte ratios as indicators of sickle cell anaemia severity","volume":"33","author":"Efobi","year":"2023","journal-title":"Ethiop J Health Sci"},{"issue":"6","key":"10.1016\/j.bvth.2026.100214_bib37","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1182\/blood-2006-12-061697","article-title":"Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin","volume":"110","author":"Villagra","year":"2007","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.bvth.2026.100214_bib38","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1182\/blood-2013-09-529420","article-title":"Platelet bioenergetic screen in sickle cell patients reveals mitochondrial complex V inhibition, which contributes to platelet activation","volume":"123","author":"Cardenes","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bvth.2026.100214_bib39","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1038\/s41467-026-68396-2","article-title":"CD39 polymorphism enables lung thrombosis in sickle cell disease","volume":"17","author":"Brzoska","year":"2026","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.bvth.2026.100214_bib40","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1161\/ATVBAHA.110.211615","article-title":"P-selectin-mediated platelet-neutrophil aggregate formation activates neutrophils in mouse and human sickle cell disease","volume":"30","author":"Polanowska-Grabowska","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"10.1016\/j.bvth.2026.100214_bib41","doi-asserted-by":"crossref","first-page":"e214","DOI":"10.3324\/haematol.2014.108555","article-title":"Prominent role of platelets in the formation of circulating neutrophil-red cell heterocellular aggregates in sickle cell anemia","volume":"99","author":"Dominical","year":"2014","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.bvth.2026.100214_bib46","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0022-3476(83)80258-3","article-title":"Trial of low doses of aspirin as prophylaxis in sickle cell disease","volume":"102","author":"Greenberg","year":"1983","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.bvth.2026.100214_bib47","first-page":"61","article-title":"Treatment of sickle cell diseases with aspirin","volume":"72","author":"Zago","year":"1984","journal-title":"Acta Haematol"},{"issue":"7","key":"10.1016\/j.bvth.2026.100214_bib48","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1512021","article-title":"A multinational trial of prasugrel for sickle cell vaso-occlusive events","volume":"374","author":"Heeney","year":"2016","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.bvth.2026.100214_bib49","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1182\/blood.2021014095","article-title":"Ticagrelor vs placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: the HESTIA3 study","volume":"140","author":"Heeney","year":"2022","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bvth.2026.100214_bib51","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1182\/blood.2022015797","article-title":"A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisis","volume":"141","author":"Dampier","year":"2023","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bvth.2026.100214_bib50","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1016\/S2352-3026(21)00053-3","article-title":"Sevuparin for the treatment of acute pain crisis in patients with sickle cell disease: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"8","author":"Biemond","year":"2021","journal-title":"Lancet Haematol"},{"issue":"5","key":"10.1016\/j.bvth.2026.100214_bib52","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1056\/NEJMoa1611770","article-title":"Crizanlizumab for the prevention of pain crises in sickle cell disease","volume":"376","author":"Ataga","year":"2017","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.bvth.2026.100214_bib53","doi-asserted-by":"crossref","first-page":"e248","DOI":"10.1016\/S2352-3026(24)00384-3","article-title":"Crizanlizumab with or without hydroxyurea in patients with sickle cell disease (STAND): primary analyses from a placebo-controlled, randomised, double-blind, phase 3 trial","volume":"12","author":"Abboud","year":"2025","journal-title":"Lancet Haematol"},{"issue":"8","key":"10.1016\/j.bvth.2026.100214_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133116","article-title":"Elevated steady state WBC and platelet counts are associated with frequent emergency room use in adults with sickle cell anemia","volume":"10","author":"Curtis","year":"2015","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.bvth.2026.100214_bib43","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1007\/s00277-025-06419-6","article-title":"Platelet-to-neutrophil ratio as a predictor of risk of complications in sickle cell disease: a valuable insight for resource-limited settings","volume":"104","author":"Efobi","year":"2025","journal-title":"Ann Hematol"},{"issue":"6","key":"10.1016\/j.bvth.2026.100214_bib44","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/bjh.17643","article-title":"Flow adhesion of whole blood to P-selectin: a prognostic biomarker for vaso-occlusive crisis in sickle cell disease","volume":"194","author":"Hines","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bvth.2026.100214_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2025.101298","article-title":"Evidence and gaps in clinical outcomes of novel pharmacologic therapies for sickle cell disease: a systematic literature review highlighting insights from clinical trials and real-world studies","volume":"73","author":"Yassin","year":"2025","journal-title":"Blood Rev"},{"issue":"18","key":"10.1016\/j.bvth.2026.100214_bib54","doi-asserted-by":"crossref","DOI":"10.1172\/JCI169608","article-title":"The predominant PAR4 variant in individuals of African ancestry worsens murine and human stroke outcomes","volume":"133","author":"Denorme","year":"2023","journal-title":"J Clin Invest"},{"issue":"suppl 1","key":"10.1016\/j.bvth.2026.100214_bib55","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1182\/blood-2025-2926","article-title":"Selective PAR1 activation mitigates pain and neuroinflammatory markers in a murine model of sickle cell disease [abstract]","volume":"146","author":"Ramadas","year":"2025","journal-title":"Blood"},{"issue":"suppl 1","key":"10.1016\/j.bvth.2026.100214_bib56","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1182\/blood-2020-139862","article-title":"Biased PAR-1 signaling regulates thrombo-inflammation in a mouse model of sickle cell disease [abstract]","volume":"136","author":"Sparkenbaugh","year":"2020","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bvth.2026.100214_bib57","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/MOH.0000000000000773","article-title":"The invisible string of coagulation, complement, iron, and inflammation in sickle cell disease","volume":"30","author":"Beckman","year":"2023","journal-title":"Curr Opin Hematol"}],"container-title":["Blood Vessels, Thrombosis & Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950327226000793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950327226000793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:01:19Z","timestamp":1791835279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950327226000793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2950327226000793"],"URL":"https:\/\/doi.org\/10.1016\/j.bvth.2026.100214","relation":{},"ISSN":["2950-3272"],"issn-type":[{"value":"2950-3272","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platelets in sickle cell disease: biomarkers, mediators, and lessons from clinical trials","name":"articletitle","label":"Article Title"},{"value":"Blood Vessels, Thrombosis & Hemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bvth.2026.100214","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100214"}}